Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2.

被引：0
|
作者：
Keller, Patricia J. [1 ]
Meyer, Rosana [1 ]
Greenwald, Emily [1 ]
Han, Xinwei [1 ]
Conery, Andrew R. [1 ]
Mertz, Jennifer A. [1 ]
Trojer, Patrick [1 ]
机构：
[1] Pharmaceut Inc, Cambridge, MA USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A18
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [41] Targeting dementias through cancer kinases inhibition
    Fagiani, Francesca
    Lanni, Cristina
    Racchi, Marco
    Govoni, Stefano
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [42] Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies
    Zhang, Jinwei
    Yang, Maoshuo
    Liu, Qian
    Xue, Xintong
    Tian, Sijia
    Hu, Xi
    Li, Mengzhe
    Li, Jintao
    Chai, Qipeng
    Liu, Fabao
    You, Xiaona
    Zhang, Yingjie
    BIOORGANIC CHEMISTRY, 2024, 153
  • [43] JARID2 and EZH2, the eminent epigenetic drivers in human cancer
    Sreeshma, Bhuvanadas
    Devi, Arikketh
    GENE, 2023, 879
  • [44] Novel epigenetic approach to relapsed mantle cell lymphoma based on dual inhibition of EZH1/EZH2
    Fujita, Shuhei
    Kagiyama, Yuki
    Honma, Daisuke
    Adachi, Nobuaki
    Araki, Kazushi
    Kitabayashi, Issay
    CANCER RESEARCH, 2017, 77
  • [45] Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
    Warrick, Joshua I.
    Raman, Jay D.
    Kaag, Matthew
    Bruggeman, Trey
    Cates, Justin
    Clark, Peter
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e1 - 258.e6
  • [46] Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
    Tang, Yujie
    Gholamin, Sharareh
    Schubert, Simone
    Willardson, Minde I.
    Lee, Alex
    Bandopadhayay, Pratiti
    Bergthold, Guillame
    Masoud, Sabran
    Nguyen, Brian
    Vue, Nujsaubnusi
    Balansay, Brianna
    Yu, Furong
    Oh, Sekyung
    Woo, Pamelyn
    Chen, Spenser
    Ponnuswami, Anitha
    Monje, Michelle
    Atwood, Scott X.
    Whitson, Ramon J.
    Mitra, Siddhartha
    Cheshier, Samuel H.
    Qi, Jun
    Beroukhim, Rameen
    Tang, Jean Y.
    Wechsler-Reya, Rob
    Oro, Anthony E.
    Link, Brian A.
    Bradner, James E.
    Cho, Yoon-Jae
    NATURE MEDICINE, 2014, 20 (07) : 732 - 740
  • [47] Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
    Yujie Tang
    Sharareh Gholamin
    Simone Schubert
    Minde I Willardson
    Alex Lee
    Pratiti Bandopadhayay
    Guillame Bergthold
    Sabran Masoud
    Brian Nguyen
    Nujsaubnusi Vue
    Brianna Balansay
    Furong Yu
    Sekyung Oh
    Pamelyn Woo
    Spenser Chen
    Anitha Ponnuswami
    Michelle Monje
    Scott X Atwood
    Ramon J Whitson
    Siddhartha Mitra
    Samuel H Cheshier
    Jun Qi
    Rameen Beroukhim
    Jean Y Tang
    Rob Wechsler-Reya
    Anthony E Oro
    Brian A Link
    James E Bradner
    Yoon-Jae Cho
    Nature Medicine, 2014, 20 : 732 - 740
  • [48] Ezh2-dependent therapies in bladder cancer: synthetic lethality
    Segovia, Cristina
    Paramio, Jesus M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (24)
  • [49] Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2
    Dudakovic, Amel
    Samsonraj, Rebekah M.
    Paradise, Christopher R.
    Galeano-Garces, Catalina
    Mol, Merel O.
    Galeano-Garces, Daniela
    Zan, Pengfei
    Galvan, M. Lizeth
    Hevesi, Mario
    Pichurin, Oksana
    Thaler, Roman
    Begun, Dana L.
    Kloen, Peter
    Karperien, Marcel
    Larson, A. Noelle
    Westendorf, Jennifer J.
    Cool, Simon M.
    van Wijnen, Andre J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (23) : 7877 - 7893
  • [50] EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation
    Campolo, Michela
    Scuderi, Sarah Adriana
    Filippone, Alessia
    Bova, Valentina
    Lombardo, Sofia Paola
    Colarossi, Lorenzo
    Sava, Serena
    Capra, Anna Paola
    De Gaetano, Federica
    Portelli, Marco
    Militi, Angela
    Esposito, Emanuela
    Paterniti, Irene
    PHARMACEUTICALS, 2024, 17 (08)
12345